Can Abortions Cause Fibroids? The Mechanism, Evidence, and Risk Timeline Explained

No, abortions do not cause fibroids. There is no established biological mechanism by which terminating a pregnancy creates uterine leiomyomas, and large cohort studies have found no increased incidence of fibroids in women who had induced abortions compared with those who did not. Fibroids are estrogen- and progesterone-sensitive tumors whose growth depends on cumulative lifetime hormone exposure, genetics, and age. An abortion abruptly lowers hormone levels, which may temporarily shrink or destabilize existing fibroids, but it does not seed new ones. The more relevant clinical question is how existing fibroids affect abortion safety, not the reverse.

The Mechanism: Why Pregnancy Hormones and Fibroids Interact

Uterine fibroids are monoclonal tumors of the myometrium, the smooth muscle layer of the uterine wall. Roughly 70 to 80 percent of fibroids carry mutations in the MED12 gene, which codes for a subunit of the mediator complex that regulates gene transcription. These mutations arise spontaneously in a single progenitor cell. Nothing about a surgical procedure, a drug regimen, or a pregnancy termination introduces that mutation.

What hormones do is feed existing fibroids. Estrogen upregulates progesterone receptors, and progesterone drives fibroid cell proliferation and extracellular matrix deposition. During pregnancy, serum estradiol rises up to 100-fold and progesterone up to 10-fold above luteal-phase levels. Fibroids with high receptor density can grow 10 to 30 percent in volume across the first trimester in about a third of pregnant women, though many fibroids stay stable or shrink.

In plain terms: pregnancy is fertilizer for fibroids that already exist. Ending a pregnancy removes the fertilizer. It does not plant new seeds.

After an abortion, hormone levels fall within 24 to 72 hours. Fibroids may shrink slightly or become less vascular. Some women notice a transient change in bleeding patterns or cramping as the uterus involutes. None of this represents the formation of a new fibroid. A fibroid large enough to detect by ultrasound takes months to years to reach 1 centimeter, so any fibroid found shortly after an abortion was almost certainly present before the pregnancy began.

How Common Are Fibroids, and How Often Do Abortions Happen?

Fibroids are the most common benign pelvic tumor in women of reproductive age. Cumulative incidence by age 50 reaches about 70 percent in White women and more than 80 percent in Black women, per long-running cohort data such as the NIEHS Uterine Fibroid Study. Prevalence on ultrasound screening in women aged 35 to 49 runs 20 to 40 percent. Roughly 25 to 30 percent of reproductive-age women have fibroids large enough to cause symptoms, and about 200,000 hysterectomies per year in the United States list fibroids as the primary indication.

Induced abortion is also common. Approximately 930,000 abortions were performed in the United States in 2020, per CDC surveillance, and about 73 million occur worldwide each year, per WHO estimates. The lifetime probability that a US woman has at least one induced abortion is roughly 24 percent.

Overlap is therefore inevitable. If roughly one in four women has an abortion and roughly seven in ten develop fibroids by age 50, millions of women will have both events in their lifetime. Temporal proximity in a patient's history is not causation, and this arithmetic is exactly why so many women believe a link exists.

The key quantified comparison: age is a far stronger predictor of fibroids than reproductive history. Fibroid incidence rises from roughly 4 percent at age 25 to more than 60 percent by age 45 in ultrasound-based studies. A woman who has an abortion at 30 and is diagnosed with a fibroid at 38 has accumulated eight more years of hormone exposure, and the age effect dwarfs any plausible effect of the procedure.

What the Research Actually Shows on Abortion and Fibroid Risk

The evidence base breaks into three groups.

Large cohort and cross-sectional studies consistently find no association. Analyses using National Health and Nutrition Examination Survey data and several European cohorts have compared fibroid prevalence in women with and without prior induced abortion and found odds ratios straddling 1.0, typically between 0.9 and 1.1. These confidence intervals include no effect.

Studies of pregnancy itself complicate the picture. Parity is generally associated with lower fibroid risk, possibly through uterine remodeling and reduced lifetime menstrual cycling. This has led to a plausible but unproven hypothesis that any pregnancy loss, including abortion, might forgo that protective effect. That hypothesis concerns a missing benefit, not a direct harm, and the effect size in parity studies is small, on the order of 10 to 20 percent relative reduction per birth.

Confounding is the central caveat. Women who have abortions differ from those who do not in age at first birth, socioeconomic status, and access to gynecologic care, all of which shape when a fibroid is detected. Detection bias matters too: a woman who has had an abortion has had at least one pelvic exam and ultrasound, making an incidental fibroid more likely to be found. Higher diagnosis rates in this group reflect better surveillance, not higher incidence.

No professional society, including ACOG and the Society of Radiologists in Ultrasound, lists prior abortion as a risk factor for fibroids.

Abortion Methods and Uterine Effects: A Comparison

Different abortion methods interact with the uterus differently, but none creates fibroids. The table separates what each method does mechanically from its documented relationship to fibroid formation.

The one genuine uterine complication tied to instrumentation is Asherman syndrome, intrauterine scarring from aggressive curettage, with historical rates of 15 to 30 percent after repeated sharp D&Cs. Scarring is not a fibroid. It can cause amenorrhea, infertility, and cyclic pain, and it is managed with hysteroscopy, not myomectomy.

Does Abortion Make Existing Fibroids Worse?

This is the question most patients actually ask, and the answer is nuanced. Fibroids can behave unpredictably during and after any pregnancy event.

During pregnancy, 10 to 30 percent of fibroids grow, particularly in the first trimester. After abortion, most either stabilize or shrink modestly. A small subset, perhaps 5 to 10 percent, undergo red degeneration, meaning acute hemorrhagic infarction of the fibroid, which produces localized pain, low-grade fever, and tenderness. Red degeneration is more common in pregnancy than after abortion, but hormone withdrawal can trigger it.

Heavy post-abortion bleeding is worth distinguishing from fibroid-related bleeding. Normal post-abortion bleeding lasts 1 to 2 weeks and totals roughly 50 to 100 milliliters. Bleeding that soaks a pad per hour for 2 hours, persists beyond 3 weeks, or is accompanied by fever above 100.4°F (38°C) points to retained tissue, infection, or a submucosal fibroid, not to a new tumor.

The clinical risk runs the other direction from the popular fear. Existing fibroids make abortion procedures harder. A fibroid larger than 4 to 5 centimeters that distorts the uterine cavity raises the risk of incomplete evacuation by roughly 2 to 3 times, and cervical fibroids can obstruct dilation. Clinicians who know about a fibroid in advance can plan for ultrasound guidance, osmotic dilators, or a referral to a higher-volume provider.

Timeline of Uterine Changes After Abortion

Tracking what happens to the uterus and to fibroid behavior over the weeks after a procedure clarifies why no new fibroid could appear in that window.

The takeaway from the timeline is that the uterus returns to its pre-pregnancy state within weeks to months. Fibroid biology resumes its ordinary trajectory. There is no post-abortion window in which new fibroids appear.

Common Misconceptions, Corrected

Several beliefs keep this question alive.

First, the timing fallacy. Fibroids found within months of an abortion are almost always pre-existing, often discovered because the pregnancy workup included an ultrasound. A fibroid must grow for years to reach clinical size.

Second, the "trauma causes tumors" belief. Uterine instrumentation does not transform myometrial cells. The one scarring complication, Asherman syndrome, is a distinct condition with distinct treatment.

Third, the protective-parity hypothesis misread as "abortion causes fibroids." Lower fibroid risk in women with multiple births is a small observational effect and may reflect selection rather than protection. It does not imply that abortion actively promotes fibroids.

Fourth, the detection-bias error. Women who have abortions are more likely to be screened, so fibroids are found more often, not formed more often.

Fifth, symptom attribution. Post-abortion cramping and bleeding are expected and are not evidence of fibroid growth. In plain terms: the symptoms people worry about are ordinary recovery, and the tumors they fear were already there.

What to Actually Do If You Have Fibroids and Are Considering Abortion

Concrete steps reduce risk and anxiety.

• Tell your provider about any known fibroids, prior myomectomy, or a history of heavy periods before the procedure, so imaging and procedure planning can be adjusted.
• Ask whether a pre-procedure ultrasound is warranted, especially if you have bulk symptoms such as pelvic pressure, frequent urination, or a visibly enlarged abdomen.
• Track bleeding volume and duration after the procedure, and use the red-flag list below to decide when to seek care.
• If you have fibroid-related heavy bleeding afterward, ask about medical options such as tranexamic acid or hormonal management rather than assuming the abortion caused new disease.
• Schedule a gynecologic follow-up at 4 to 6 weeks if symptoms persist, and request imaging if a fibroid is suspected for the first time.

Red-flag symptoms that warrant urgent evaluation:

• Saturating one pad per hour for 2 or more consecutive hours.
• Fever at or above 100.4°F (38°C).
• Foul-smelling vaginal discharge.
• Severe or worsening pelvic pain not relieved by over-the-counter NSAIDs.
• Bleeding that persists beyond 3 weeks or restarts after settling.

Limitations of the Evidence and What Remains Uncertain

Honesty requires naming the gaps. Most large fibroid cohorts did not ask about abortion history in detail, so exposure misclassification is possible. Few studies separate first-trimester from second-trimester procedures, or medication from surgical methods, with enough statistical power to detect small effects. Fibroid incidence also varies by race and genetics by a factor of two to three, and most cohorts underrepresent Black women, who have the highest burden.

The possibility of a very small effect on fibroid timing, rather than on fibroid formation, cannot be excluded. But even a hypothetical effect of that size would be swamped by age, genetics, and body mass index, each of which carries effect sizes an order of magnitude larger. The current best synthesis, grounded in mechanism and consistent observational data, is that abortion is not a cause of fibroids and that clinical attention belongs on managing existing fibroids safely during any pregnancy event.